News|Articles|August 1, 2025
FDA updates in urology: July 2025
Author(s)Hannah Clarke
Fact checked by: Benjamin P. Saylor, Strategic Content Lead
A recap of the FDA submissions and regulatory decisions in urology from July 2025.
Advertisement
Advertisement
Welcome to Urology Times’® monthly FDA update! In July, notable advancements were made in the development of a combination regimen for metastatic prostate cancer, an emerging agent in non–muscle invasive bladder cancer (NMIBC), a medication for hypoactive sexual desire disorder (HSDD), and more.
Advertisement
Advertisement